Sandra Levy
ARTICLES BY THIS AUTHOR
- 6/17/2020
New York law empowers pharmacists to vaccinate against COVID-19
A New York law signed on June 17 will allow pharmacists to vaccinate New Yorkers against COVID-19 once a vaccine is available. - 6/17/2020
District Court ruling on Tecfidera patent opens door for Mylan's generic
Tecfidera had a market value of roughly $3.78 billion for the 12 months ended April 30, according to IQVIA. - 6/17/2020
NACDS responds to Wall Street Journal editorial on pharmacy value
Steve Anderson, president and CEO of the National Association of Chain Drug Stores, responded to a recent Wall Street Journal editorial that he said ignores the role pharmacies and pharmacists play in patient health. - 6/17/2020
Zydus Cadila obtains FDA green light for generic Jadenu
Zydus Cadila’s generic Jadenu will be available in dosage strengths of 90 mg, 180 mg and 360 mg. - 6/16/2020
NACDS’ Anderson to serve as ASAE chair-elect, lead foundation board
The National Association of Chain Drug Stores' Steve Anderson will serve as chair of the American Society of Association Executives board of directors beginning Sept. 1, 2021. - 6/16/2020
Schnucks to celebrate EatWell grand opening
EatWell, A Natural Food Store by Schnucks, features organic produce, a natural living section, freshly squeezed juices and clean-label indulgences, the company said. - 6/16/2020
GoodRx taps former McKesson exec to lead corporate strategy
Bansi Nagji, previously McKesson's executive vice president and chief strategy and business development officer, will serve as GoodRx's president of health care. - 6/15/2020
Hy-Vee exceeds $1M goal to support local food banks
Since the start of Hy-Vee's fundraising campaign, more than $1,082,000 has been raised to provide supplies to 17 Feeding America-affiliated food banks. - 6/15/2020
Valeo Pharma receives FDA OK for ethacrynate sodium
Valeo's ethacrynate sodium will be launched this summer. - 6/14/2020
PQS, Humana launch outcomes-based diabetes pilot program
Pharmacy Quality Solutions and Humana are piloting the first diabetes outcomes-based program within the EQuIPP platform.
